GFT505

CAS No. 824932-88-9

GFT505( Elafibranor )

Catalog No. M28578 CAS No. 824932-88-9

GFT505 (Elafibranor) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 49 In Stock
2MG 30 In Stock
5MG 48 In Stock
10MG 61 In Stock
25MG 106 In Stock
50MG 173 In Stock
100MG 267 In Stock
200MG 401 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GFT505
  • Note
    Research use only, not for human use.
  • Brief Description
    GFT505 (Elafibranor) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively.
  • Description
    GFT505 (Elafibranor) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Elafibranor
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    824932-88-9
  • Formula Weight
    384.49
  • Molecular Formula
    C22H24O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C(O)=O)Oc1c(C)cc(C=CC(c(cc2)ccc2SC)=O)cc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Todd JS, Gerwick WH. Isolation of a cyclic carbonate, a gamma-butyrolactone, and a new indole derivative from the marine cyanobacterium Lyngbya majuscula. J Nat Prod. 1995 Apr;58(4):586-9.
molnova catalog
related products
  • GSK3787

    GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ.

  • Muraglitazar

    Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia.

  • LJ570

    LJ570 is the first PPARα/γ dual agonist (PPARαPPARγ with EC50s of 1.05 and 0.12 μM respectively.